Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical cetirizine for androgenetic alopecia
IRCT20161207031288N3Phase 3Completed
- Sponsor
- Center for Research and Training in Skin Diseases and Leprosy
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of cetirizine in androgenetic alopecia (AGA), sponsored by Center for Research and Training in Skin Diseases and Leprosy. Started Jan 2018; status: completed.
02
Drugs
cetirizine
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on IRCT20161207031288N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20161207031288N3.